0001209191-11-021602.txt : 20110405 0001209191-11-021602.hdr.sgml : 20110405 20110405162519 ACCESSION NUMBER: 0001209191-11-021602 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110401 FILED AS OF DATE: 20110405 DATE AS OF CHANGE: 20110405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BREITMEYER JAMES B CENTRAL INDEX KEY: 0001244823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33103 FILM NUMBER: 11740367 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CADENCE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001333248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8584361400 MAIL ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-04-01 0 0001333248 CADENCE PHARMACEUTICALS INC CADX 0001244823 BREITMEYER JAMES B C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 EVP, CMO common stock 2011-04-01 4 M 0 7000 3.20 A 17000 D common stock 2011-04-01 4 S 0 7000 9.20 D 10000 D stock option (right to buy) 3.20 2011-04-01 4 M 0 7000 D 2006-08-14 2016-08-13 common stock 7000 76250 D The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2010. Not applicable to this transaction. Hazel M. Aker Attorney-in-fact 2011-04-05